Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Saenger

Showing results (21-30 of 41) with videos related to

Pageof 5
Sort By:
Hormone Research|August 22, 2003
Presentation and 5-year follow-up of type 2 diabetes mellitus in African-American and Caribbean-Hispanic adolescentsGabriela Grinstein, Radhika Muzumdar, Leonor Aponte, et al.
The Journal of Clinical Endocrinology and Metabolism|December 29, 2021
Effective GH Replacement With Once-weekly Somapacitan vs Daily GH in Children with GHD: 3-year Results From REAL 3Lars Sävendahl, Tadej Battelino, Michael Højby Rasmussen, et al.
European Journal of Endocrinology|December 17, 2008
Pharmacokinetic and pharmacodynamic profile of a new sustained-release GH formulation, LB03002, in children with GH deficiencyFerenc Peter, Conrad Savoy, Hyi-Jeong Ji, et al.
Hormone Research|May 15, 2002
Assessing insulin resistance: application of a fasting glucose to insulin ratio in growth hormone-treated childrenTania S Burgert, Patricia M Vuguin, Joan DiMartino-Nardi, et al.
Hormone Research in Paediatrics|November 13, 2013
Trends in the incidence of childhood type 1 diabetes mellitus in Beijing based on hospitalization data from 1995 to 2010Chunxiu Gong, Xi Meng, Paul Saenger, et al.
Journal of the Endocrine Society|December 15, 2025
Seven-year Safety and Efficacy of Somapacitan in Children With GH Deficiency: Final Results From REAL 3Lars Sävendahl, Tadej Battelino, Michael Højby, et al.
The Journal of Clinical Endocrinology and Metabolism|March 30, 2023
Weekly Somapacitan in GH Deficiency: 4-Year Efficacy, Safety, and Treatment/Disease Burden Results From REAL 3Lars Sävendahl, Tadej Battelino, Michael Højby Rasmussen, et al.
The Journal of Clinical Endocrinology and Metabolism|January 10, 2020
Once-Weekly Somapacitan vs Daily GH in Children With GH Deficiency: Results From a Randomized Phase 2 TrialLars Sävendahl, Tadej Battelino, Meryl Brod, et al.
Biologics in Therapy|August 7, 2014
Switching to Omnitrope(®) from Other Recombinant Human Growth Hormone Therapies: A Retrospective Study in an Integrated Healthcare SystemNazia Rashid, Paul Saenger, Yi-Lin Wu, et al.
Journal of Pediatric Endocrinology & Metabolism : JPEM|June 20, 2014
Clinical characteristics and chromosome 11p15 imprinting analysis of Silver-Russell syndrome - a Chinese experienceDi Wu, Chunxiu Gong, Huyong Zheng, et al.
Pageof 5

Showing results (21-30 of 41) with videos related to

Sort By:
Pageof 5
Hormone Research|August 22, 2003
Presentation and 5-year follow-up of type 2 diabetes mellitus in African-American and Caribbean-Hispanic adolescentsGabriela Grinstein, Radhika Muzumdar, Leonor Aponte, et al.
The Journal of Clinical Endocrinology and Metabolism|December 29, 2021
Effective GH Replacement With Once-weekly Somapacitan vs Daily GH in Children with GHD: 3-year Results From REAL 3Lars Sävendahl, Tadej Battelino, Michael Højby Rasmussen, et al.
European Journal of Endocrinology|December 17, 2008
Pharmacokinetic and pharmacodynamic profile of a new sustained-release GH formulation, LB03002, in children with GH deficiencyFerenc Peter, Conrad Savoy, Hyi-Jeong Ji, et al.
Hormone Research|May 15, 2002
Assessing insulin resistance: application of a fasting glucose to insulin ratio in growth hormone-treated childrenTania S Burgert, Patricia M Vuguin, Joan DiMartino-Nardi, et al.
Hormone Research in Paediatrics|November 13, 2013
Trends in the incidence of childhood type 1 diabetes mellitus in Beijing based on hospitalization data from 1995 to 2010Chunxiu Gong, Xi Meng, Paul Saenger, et al.
Journal of the Endocrine Society|December 15, 2025
Seven-year Safety and Efficacy of Somapacitan in Children With GH Deficiency: Final Results From REAL 3Lars Sävendahl, Tadej Battelino, Michael Højby, et al.
The Journal of Clinical Endocrinology and Metabolism|March 30, 2023
Weekly Somapacitan in GH Deficiency: 4-Year Efficacy, Safety, and Treatment/Disease Burden Results From REAL 3Lars Sävendahl, Tadej Battelino, Michael Højby Rasmussen, et al.
The Journal of Clinical Endocrinology and Metabolism|January 10, 2020
Once-Weekly Somapacitan vs Daily GH in Children With GH Deficiency: Results From a Randomized Phase 2 TrialLars Sävendahl, Tadej Battelino, Meryl Brod, et al.
Biologics in Therapy|August 7, 2014
Switching to Omnitrope(®) from Other Recombinant Human Growth Hormone Therapies: A Retrospective Study in an Integrated Healthcare SystemNazia Rashid, Paul Saenger, Yi-Lin Wu, et al.
Journal of Pediatric Endocrinology & Metabolism : JPEM|June 20, 2014
Clinical characteristics and chromosome 11p15 imprinting analysis of Silver-Russell syndrome - a Chinese experienceDi Wu, Chunxiu Gong, Huyong Zheng, et al.
Pageof 5